ALL, ADULT
Clinical trials for ALL, ADULT explained in plain language.
Never miss a new study
Get alerted when new ALL, ADULT trials appear
Sign up with your email to follow new studies for ALL, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for T-ALL: drug that clears hidden cancer cells after chemotherapy
Disease control TerminatedThis study tested whether the drug daratumumab can eliminate tiny amounts of leukemia cells that remain after standard chemotherapy in adults with T-cell acute lymphoblastic leukemia (T-ALL). These remaining cells, called minimal residual disease (MRD), raise the risk of the canc…
Matched conditions: ALL, ADULT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 17, 2026 10:26 UTC
-
New hope for tough leukemias: targeted pill BN104 enters human trials
Disease control OngoingThis study tests a new drug called BN104 in 66 adults with acute leukemia that has come back or not responded to other treatments. The drug targets specific genetic changes (KMT2A or NPM1 mutations) to try to control the disease. The goal is to find the safest dose and see if it …
Matched conditions: ALL, ADULT
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.) • Aim: Disease control
Last updated May 17, 2026 10:26 UTC
-
Can early comfort care improve end of life for leukemia patients?
Symptom relief OngoingThis study looks at whether starting palliative care early helps adults with relapsed or high-risk leukemia or myelodysplastic syndrome. About 105 participants will get either early palliative care or standard care. The goal is to see if it improves where they die and reduces hos…
Matched conditions: ALL, ADULT
Phase: NA • Sponsor: University of Virginia • Aim: Symptom relief
Last updated May 08, 2026 12:01 UTC